Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Nutrition Continues Launches Despite Divestment Possibility

This article was originally published in The Tan Sheet

Executive Summary

Pfizer remains active in its international nutritionals business with the launch of an expanded line of pediatric products, even as the company considers divesting the nutrition unit.

You may also be interested in...



Nestle To Become No. 1 In China's Infant Formula Market Following Pfizer Nutrition Acquisition

With roughly 60% of Pfizer Nutrition sales coming from Asia, and 47% of that from China, Nestle slips into No. 1 spot in China’s infant formula market.

Nestle To Become No. 1 In China's Infant Formula Market Following Pfizer Nutrition Acquisition

With roughly 60% of Pfizer Nutrition sales coming from Asia, and 47% of that from China, Nestle slips into No. 1 spot in China’s infant formula market.

Pfizer CEO Read Expects Gradual Plans For Change In Second Half 2011

Pfizer expects to unveil restructuring plans, including the potential divestiture of its Consumer Healthcare and Nutrition units, in the second half of 2011.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105024

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel